CHRISTINE BERNDT: Open Payments
NPI 1194103853 · SURING, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 13 payments from 7 companies in 2025. Trend: 2023 $394 · 2024 $210 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Amgen Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $17 |
| Tris Pharma Inc | 1 | $17 |
Products named: Ozempic, JARDIANCE, REXULTI, CAPLYTA, OTEZLA, MOUNJARO, Dyanavel XR.
Industry payments across WI — which companies pay providers there.
